Intrasense SA announced a private placement of 20,000,000 common shares at an issue price of 0.44 per share for gross proceeds of 8,800,000 on January 11, 2023. The transaction included participation from new investor, Guerbet SA for a 39% stake.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.316 EUR | -3.66% | -2.77% | -12.22% |
Apr. 17 | Intrasense: an innovative solution for cancer monitoring | CF |
Apr. 09 | Guerbet: CE certificate for a platform | CF |
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
37.4 EUR | +4.32% | +10.65% | 502M | ||
0.316 EUR | -3.66% | -2.77% | 17.61M | ||
1st Jan change | Capi. | |
---|---|---|
-12.22% | 17.61M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- ALINS Stock
- News Intrasense
- Intrasense SA announced that it has received €8.8 million in funding from Guerbet SA